Wang et al. (2015) used two similar breast cancer cell lines to investigate the proteomic changes associated with, and potentially responsible for, resistance to chemotherapy. By investigating the differences at the translational level, the research team sought to characterize pathways that might present new insights of potential therapeutic importance in this disease. Adriamycin is an anthracycline Read the rest of this article
The post Proteomics Changes Associated with Resistance to Chemotherapy appeared first on Accelerating Science.